Package 69238-1993-1
Brand: butalbital, aspirin, caffeine and codeine phosphate
Generic: butalbital, aspirin, caffeine and codeine phosphatePackage Facts
Identity
Package NDC
69238-1993-1
Digits Only
6923819931
Product NDC
69238-1993
Description
100 CAPSULE in 1 BOTTLE (69238-1993-1)
Marketing
Marketing Status
Brand
butalbital, aspirin, caffeine and codeine phosphate
Generic
butalbital, aspirin, caffeine and codeine phosphate
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f3869a7a-b5f3-4279-b07b-ff01a8c2a286", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175693", "M0002177", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0369238199314"], "unii": ["R16CO5Y76E", "KHS0AZ4JVK", "3G6A5W338E", "GSL05Y1MN6"], "rxcui": ["994237"], "spl_set_id": ["828e30fa-7bb1-486b-80ee-806fce45e4e4"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Barbiturates [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Barbiturate [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals of New York, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (69238-1993-1)", "package_ndc": "69238-1993-1", "marketing_start_date": "20190401"}], "brand_name": "BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE", "product_id": "69238-1993_f3869a7a-b5f3-4279-b07b-ff01a8c2a286", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Barbiturate [EPC]", "Barbiturates [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Full Opioid Agonists [MoA]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Opioid Agonist [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "69238-1993", "dea_schedule": "CIII", "generic_name": "BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE", "labeler_name": "Amneal Pharmaceuticals of New York, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "BUTALBITAL", "strength": "50 mg/1"}, {"name": "CAFFEINE", "strength": "40 mg/1"}, {"name": "CODEINE PHOSPHATE", "strength": "30 mg/1"}], "application_number": "ANDA074951", "marketing_category": "ANDA", "marketing_start_date": "20190401", "listing_expiration_date": "20271231"}